ArticleBritish journal of haematology2017

Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.

Danka Cholujova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.